Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Laura Catherine Edney"'
Autor:
Laura Vallejo-Torres, Borja García-Lorenzo, Laura Catherine Edney, Niek Stadhouders, Ijeoma Edoka, Iván Castilla-Rodríguez, Lidia García-Pérez, Renata Linertová, Cristina Valcárcel-Nazco, Jonathan Karnon
Publikováno v:
Applied Health Economics and Health Policy. 20:337-349
Autor:
Mike Paulden, James Lomas, Laura Catherine Edney, Jonathan Karnon, Jonathan Siverskog, Niek Stadhouders, Laura Vallejo-Torres, Ijeoma Edoka, Jessica Ochalek
Publikováno v:
Pharmacoeconomics
Many health technology assessment committees have an explicit or implicit reference value (often referred to as a ‘threshold’) below which new health technologies or interventions are considered value for money. The basis for these reference valu
Publikováno v:
Diabetic Medicine. 39
AIMS This pragmatic review aimed to map and summarize the literature on model of care interventions to prevent inpatient hypoglycaemia. Model of care interventions were broadly defined as interventions that either directly target the workforce or whe
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(5)
Individuals diagnosed with cancer have a range of supportive care needs that are often unmet despite substantial evidence supporting interventions to address them. Addressing this knowledge-translation gap represents a significant opportunity to impr
Publikováno v:
Journal of Cancer Policy. 26:100257
Background Multidisciplinary Teams (MDTs) are widely used in oncology care, but their cost-effectiveness has not been established. Evidence suggests they are an expensive service to provide and that their effectiveness varies by attendee and patient
Publikováno v:
Australian health review : a publication of the Australian Hospital Association. 43(5)
The Australian health system performs well compared with other developed countries, but there is potential for improved health outcomes through the consideration of the opportunity costs of funding new health services. The opportunity costs of fundin
Publikováno v:
Journal of health services researchpolicy. 23(2)
Health technology assessment provides a common framework for evaluating the costs and benefits of new health technologies to inform decisions on the public funding of new pharmaceuticals and other health technologies. In Australia and England, empiri
Publikováno v:
PharmacoEconomics. 36(2)
Spending on new healthcare technologies increases net population health when the benefits of a new technology are greater than their opportunity costs—the benefits of the best alternative use of the additional resources required to fund a new techn
Publikováno v:
Health policy (Amsterdam, Netherlands). 122(8)
There is limited empirical evidence of the nature of any relationship between health spending and health outcomes in Australia. We address this by estimating the elasticity of health outcomes with respect to public healthcare spending using an instru
Publikováno v:
Value in Health. 20:A685